ResearcherHarbin Medical UniversityNo recent work listed

Kaidong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7520-2235; OpenAlex author ID A5101801085. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma. Co-author DOI 10.1002/1878-0261.13279 ↗
A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level. Co-author DOI 10.1016/j.omtn.2021.10.014 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yunyan Gu · 2 shared papers, 2021–2022 · strength 0.26
- Paper Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma. DOI 10.1002/1878-0261.13279 ↗
- Paper A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level. DOI 10.1016/j.omtn.2021.10.014 ↗
Min Zou · 2 shared papers, 2021–2022 · strength 0.26
- Paper Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma. DOI 10.1002/1878-0261.13279 ↗
- Paper A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level. DOI 10.1016/j.omtn.2021.10.014 ↗
Shuliang Wu · 1 shared paper, 2022 · strength 0.14
- Paper Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma. DOI 10.1002/1878-0261.13279 ↗
Shuping Zhuang · 1 shared paper, 2021 · strength 0.12
- Paper A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level. DOI 10.1016/j.omtn.2021.10.014 ↗
Zhiqiang Chang · 1 shared paper, 2021 · strength 0.12
- Paper A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level. DOI 10.1016/j.omtn.2021.10.014 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.